Transaction Details

Footnotes

Represents the exercise of Stock Appreciation Rights ("SARs") expiring on March 31, 2027, for which the reporting person exercised all 6,401 shares. | This represents the difference between the number of SARs exercised (6,401) and the number of shares issued as a result of the exercise (1,110) The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($95.00) and the exercise price ($78.53). | Represents the exercise of SARs expiring on June 15, 2026, for which the reporting person exercised all 10,000 shares. | This represents the difference between the number of SARs exercised (10,000) and the number of shares issued as a result of the exercise (2,700). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($94.64) and the exercise price ($69.14). | Represents shares of common stock sold in the open market on September 29, 2025 pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.36 to $95.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range specified herein.